These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10807758)

  • 1. The A -844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriers.
    Morange PE; Henry M; Tregouët D; Granel B; Aillaud MF; Alessi MC; Juhan-Vague I
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1387-91. PubMed ID: 10807758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.
    Akhter MS; Biswas A; Ranjan R; Meena A; Yadav BK; Sharma A; Saxena R
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):184-8. PubMed ID: 19419975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
    Sundquist K; Wang X; Svensson PJ; Sundquist J; Hedelius A; Larsson Lönn S; Zöller B; Memon AA
    Thromb Haemost; 2015 Nov; 114(6):1156-64. PubMed ID: 26245493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
    Procare-GEHT Group
    Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects.
    Seguí R; Estellés A; Mira Y; España F; Villa P; Falcó C; Vayá A; Grancha S; Ferrando F; Aznar J
    Br J Haematol; 2000 Oct; 111(1):122-8. PubMed ID: 11091191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V Leiden mutation and PAI-1 gene 4G/5G genotype in thrombotic patients with Behcet's disease.
    Gurgey A; Balta G; Boyvat A
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):121-4. PubMed ID: 12632020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.
    Prabhudesai A; Shetty S; Ghosh K; Kulkarni B
    Eur J Haematol; 2017 Sep; 99(3):249-254. PubMed ID: 28561456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV1691 G-A.
    Akar N; Yilmaz E; Akar E; Avcu F; Yalçin A; Cin S
    Thromb Res; 2000 Feb; 97(4):227-30. PubMed ID: 10674409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
    Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
    Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia.
    Fabbro D; D'Elia AV; Spizzo R; Driul L; Barillari G; Di Loreto C; Marchesoni D; Damante G
    Gynecol Obstet Invest; 2003; 56(1):17-22. PubMed ID: 12867763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
    Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
    Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the -675 4G/5G dimorphism of the plasminogen activator inhibitor 1 promoter on thrombotic risk in patients with factor V Leiden.
    Visanji JM; Seargent J; Tahri D; Croft SA; Makris M; Preston FE; Peake IR; Daly ME
    Br J Haematol; 2000 Jul; 110(1):135-8. PubMed ID: 10930990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major and potential prothrombotic genotypes in a cohort of patients with venous thromboembolism.
    Varela ML; Adamczuk YP; Forastiero RR; Martinuzzo ME; Cerrato GS; Pombo G; Carreras LO
    Thromb Res; 2001 Dec; 104(5):317-24. PubMed ID: 11738073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
    Magdoud K; Herbepin VG; Touraine R; Almawi WY; Mahjoub T
    Am J Reprod Immunol; 2013 Sep; 70(3):246-52. PubMed ID: 23521508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome.
    Tàssies D; Espinosa G; Muñoz-Rodríguez FJ; Freire C; Cervera R; Monteagudo J; Maragall S; Escolar G; Ingelmo M; Ordinas A; Font J; Reverter JC
    Arthritis Rheum; 2000 Oct; 43(10):2349-58. PubMed ID: 11037896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women.
    Jusić A; Balić D; Avdić A; Pođanin M; Balić A
    Med Glas (Zenica); 2018 Aug; 15(2):158-163. PubMed ID: 29703881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden, prothrombin 20210G --> A, methylenetetrahydrofolate reductase 677C --> T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism.
    Meglic L; Stegnar M; Milanez T; Bozic M; Peterlin B; Peternel P; Novak-Antolic Z
    Eur J Obstet Gynecol Reprod Biol; 2003 Dec; 111(2):157-63. PubMed ID: 14597244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
    Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.